How to access Ubrelvy from the UAE, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Emirati patient who experiences disabling migraine attacks that are poorly controlled by, or contraindicated for, triptans may receive a prescription for Ubrelvy (ubrogepant) from their treating neurologist or headache-clinic physician. Ubrelvy is FDA-approved for the acute treatment of migraine with or without aura in adults. It is manufactured by AbbVie (Allergan) and was one of the first oral CGRP receptor antagonists approved for acute migraine. In the UAE, Ubrelvy may not yet be broadly stocked through hospital formularies, which is why your neurologist may be navigating a named-patient import pathway with you.
This guide explains the legal pathway, what your physician needs to provide, typical timelines, and where Reserve Meds fits in.
Ask about Ubrelvy in UAE
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Ubrelvy is an oral tablet taken as a 50 mg or 100 mg dose at the onset of a migraine attack, with an optional second dose at least two hours later (maximum 200 mg in 24 hours). As a gepant, it provides a non-vasoconstrictor alternative to triptans, which makes it particularly useful for patients with cardiovascular disease, uncontrolled hypertension, or prior adverse triptan experience. It does not replace preventive therapy, that is a separate clinical decision. Your neurologist determines eligibility based on attack pattern, prior therapy history, and comorbidities.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Ubrelvy legally importable into the UAE?
Yes, through the UAE Ministry of Health and Prevention (MoHAP) named-patient framework, with parallel authority through DoH Abu Dhabi and DHA Dubai depending on the prescribing facility. The pathway allows an Emirati-licensed physician to import a medicine not locally registered when: (a) the medicine is approved by a recognised reference authority (FDA qualifies), (b) no locally available alternative is clinically equivalent for the patient, (c) the physician takes clinical responsibility, and (d) chain of custody is documented.
For Ubrelvy specifically, the application is routine, an oral tablet with standard room-temperature handling and no REMS or cold-chain complexity.
How the pathway works, step by step
- Consultation with your treating neurologist. Migraine diagnosis per ICHD-3 criteria, documentation of prior triptan trials or triptan contraindications, and the clinical rationale for a gepant.
- MoHAP / DoH / DHA named-patient application. Your physician files the application including clinical letter, patient identifier, and product details.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure the product from the manufacturer's authorised distribution chain.
- Shipment. Ubrelvy ships at controlled room temperature; no cold-chain is required.
- Arrival and dispensing. The receiving facility dispenses per your neurologist's direction.
What documentation your physician needs
Your physician will typically need to provide:
- Clinical rationale letter confirming migraine diagnosis, attack frequency, prior triptan or other acute-therapy history, and Ubrelvy as the indicated acute treatment
- Verification of the UAE medical licence
- Patient identifier
- Prescribed dose and projected monthly tablet count
Reserve Meds provides a physician documentation kit that bundles the templates MoHAP reviewers expect to see.
Costs and timing
Medicine price: quote on request. You get a written quote for your case before you commit. Shipment, documentation, and coordination add incremental cost; Reserve Meds issues a full transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. Refills ship on a rolling basis once the pathway is established.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
Reserve Meds's role
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Ubrelvy specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and for MoHAP/DoH/DHA review.
- Logistics. Controlled-room-temperature shipment coordination.
- Dedicated case lead. A named point of contact throughout.
What we do not do: We are not the prescriber. We do not practise medicine. We are not the dispensing pharmacy. All clinical decisions remain with your treating neurologist.
Frequently asked
Is this legal in the UAE? Yes, when executed through the MoHAP named-patient framework with appropriate documentation.
How is Ubrelvy different from Nurtec? Both are gepants. Ubrelvy is approved for acute migraine only; Nurtec is approved for both acute and preventive use. The clinical choice depends on whether you need rescue only, prevention, or both.
Can I use Ubrelvy alongside a preventive like a CGRP monoclonal? Yes, gepant acute therapy is commonly combined with preventive therapy (erenumab, fremanezumab, galcanezumab, eptinezumab, or atogepant) under neurologist supervision. The regimens are complementary.
Will private insurance cover this? Cash-pay is the default. Some UAE private insurers reimburse named-patient imports; we supply documentation for your submission but do not process insurance claims directly.
Recent regulatory and access news for Ubrelvy in the UAE
The Ministry of Health and Prevention (MoHAP) drug registration database at mohap.gov.ae has not added Ubrelvy to the registered products list over the last 12 months as of 2026-06-04. The Dubai Health Authority drug list at dha.gov.ae and the Department of Health Abu Dhabi formulary at doh.gov.ae have not added Ubrelvy to their formularies. AbbVie continues commercial rollout of ubrogepant for acute migraine treatment in adults; the International Headache Society and the Emirates Neurological Society continue to position gepants as an acute-attack option for patients with triptan contraindications or insufficient response. We update this section on each case file at intake; the snapshot date governs.
Next step
For Ubrelvy coordination in the UAE, start your case at the portal or message us on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.
Examples and timings above are composite illustrations drawn from published sources and typical named-patient patterns. Your individual case is assessed by your physician and our clinical-regulatory team; Reserve Meds does not guarantee outcomes or timelines.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Abu Dhabi and Dubai
This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.
In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.
Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.
Frequently asked questions
How can I get Ubrelvy in the UAE if it is not approved or available there?
Reserve Meds coordinates US-sourced Ubrelvy for patients in the UAE through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for the UAE and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Ubrelvy in the UAE through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Ubrelvy. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in the UAE, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Ubrelvy in the UAE through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Ubrelvy to a patient in the UAE?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Ubrelvy to your treating physician or hospital pharmacy in the UAE, with appropriate handling for the product.
How long does it take, and what does Ubrelvy in the UAE cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Ubrelvy in the UAE?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.